Home About Us LungVantage Active Targeting Research Leadership News Contact Viomics - Early Detection of Cancer
Who are we?

Viomics is a molecular diagnostics company that utilizes innovative strategies to discover, develop, and deliver products aimed at accurately detecting an array of cancer types early.
  How can I help

We are currently looking for partners for our prospective clinical trials and discussing licensing opportunities. Laboratories, pulmonologists and radiologists are encouraged to contact us at info@viomics.com

  Breaking news
  • Viomics launches clinical trials for LungVantage

  • Viomics executive team publishes a manuscript in the top-tier journal Nature outlining discoveries in lung cancer.

  • Viomics launches ActiveTargeting™ technologies to monitor treatment response in real-time.


©Copyright 2012 Viomics Inc. All rights reserved.